Patents by Inventor Lorna Anne Duffy

Lorna Anne Duffy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazole derivatives as p38 MAP inhibitors
    Patent number: 9249125
    Abstract: Compounds of formula (I): wherein R1, R2, J, Q, V, X, Y and Z are defined herein are disclosed. The compounds are inhibitors of the family of p38 mitogen-activated protein kinase enzymes (referred to herein as p38 MAP kinase inhibitors), particularly the alpha sub-type thereof, and of Syk kinase and the Src family of tyrosine kinases. The compounds may be used in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, in particular inflammatory diseases of the lung, such as asthma and COPD, as well as those of the gastrointestinal tract, such as ulcerative colitis and Crohn's disease and of the eye, such as uveitis.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: February 2, 2016
    Assignees: RESPIVERT LIMITED, TOPIVERT PHARMA LIMITED
    Inventors: Lorna Anne Duffy, John King-Underwood, Alistair Ian Longshaw, Peter John Murray, Stuart Thomas Onions, David Michael Adrien Taddei, Jonathan Gareth Williams, Kazuhiro Ito, Catherine Elisabeth Charron
  • PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS
    Publication number: 20150203475
    Abstract: Compounds of formula (I): wherein R1, R2, J, Q, V, X, Y and Z are defined herein are disclosed. The compounds are inhibitors of the family of p38 mitogen-activated protein kinase enzymes (referred to herein as p38 MAP kinase inhibitors), particularly the alpha sub-type thereof, and of Syk kinase and the Src family of tyrosine kinases. The compounds may be used in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, in particular inflammatory diseases of the lung, such as asthma and COPD, as well as those of the gastrointestinal tract, such as ulcerative colitis and Crohn's disease and of the eye, such as uveitis.
    Type: Application
    Filed: August 28, 2013
    Publication date: July 23, 2015
    Applicant: TOPIVERT PHARMA LIMITED
    Inventors: Lorna Anne Duffy, John King-Underwood, Alistair Ian Longshaw, Peter John Murray, Stuart Thomas Onions, David Michael Adrien Taddei, Jonathan Gareth Williams, Kazuhiro Ito, Catherine Elisabeth Charron